Pleural effusion
There is a potential space between the visceral and parietal layers of the pleura, called the pleural cavity. Under normal circumstances, the width between the two layers of pleura in the pleural cavity is about 10 to 20 μm, containing serous fluid, about 0.1 to 0.2 ml per kilogram of body weight, which is usually colorless and transparent, and plays a role in lubricating the pleura. Its exudation and reabsorption are in a state of balance. If any factor causes an increase in exudation and (or) a decrease in reabsorption, fluid will accumulate in the pleural cavity, forming pleural effusion.
-
Site of disease:
Chest -
Infectious :
Not contagious -
Frequent population:
All groups -
Related symptoms:
Chest pain dyspnea chest tightness diminished breath sounds pleural friction sound -
Concurrent disease:
Related Drugs
Group A Streptococcus for injection
Indication: Clinical trials have shown that intracavitary treatment is effective in treating malignant pleural effusions, and intratumoral and systemic medications have certain effects on solid tumors. They can be used in conjunction with surgery, radiotherapy or chemotherapy for the adjuvant treatment of malignant tumors.
Manufacturer:
Sinopharm Group Luya(Shandong)Pharmaceutical Co., Ltd.